Both clinical DN samples and mesangial cells treated with high glucose exhibited reduced levels of Nrf2 and its downstream targets, including HO-1, NQO-1, GCLC, and GCLM. The gene discussed is NFE2L2; the disease is liver dysplastic nodule.